168 related articles for article (PubMed ID: 33605429)
1. Flow cytometry reveals the nuances of clonal haematopoiesis.
Hasserjian RP
Br J Haematol; 2021 Mar; 192(6):949-950. PubMed ID: 33605429
[No Abstract] [Full Text] [Related]
2. Clinical Flow Cytometry Analysis in the Setting of Chronic Myeloid Neoplasms and Clonal Hematopoiesis.
El Hussein S; Loghavi S
Clin Lab Med; 2023 Sep; 43(3):411-426. PubMed ID: 37481320
[TBL] [Abstract][Full Text] [Related]
3. Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis.
Dillon LW; Ghannam J; Nosiri C; Gui G; Goswami M; Calvo KR; Lindblad KE; Oetjen KA; Wilkerson MD; Soltis AR; Sukumar G; Dalgard CL; Thompson J; Valdez J; DeStefano CB; Lai C; Sciambi A; Durruthy-Durruthy R; Llanso A; Gulati S; Wang S; Ooi A; Dagur PK; McCoy JP; Burr P; Li Y; Hourigan CS
Blood Cancer Discov; 2021 Jul; 2(4):319-325. PubMed ID: 34258102
[TBL] [Abstract][Full Text] [Related]
4. Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia.
Hasserjian RP; Steensma DP; Graubert TA; Ebert BL
Blood; 2020 May; 135(20):1729-1738. PubMed ID: 32232484
[TBL] [Abstract][Full Text] [Related]
5. Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
Jongen-Lavrencic M; Grob T; Hanekamp D; Kavelaars FG; Al Hinai A; Zeilemaker A; Erpelinck-Verschueren CAJ; Gradowska PL; Meijer R; Cloos J; Biemond BJ; Graux C; van Marwijk Kooy M; Manz MG; Pabst T; Passweg JR; Havelange V; Ossenkoppele GJ; Sanders MA; Schuurhuis GJ; Löwenberg B; Valk PJM
N Engl J Med; 2018 Mar; 378(13):1189-1199. PubMed ID: 29601269
[TBL] [Abstract][Full Text] [Related]
6. How Do We Use Multicolor Flow Cytometry to Detect Minimal Residual Disease in Acute Myeloid Leukemia?
Xu J; Jorgensen JL; Wang SA
Clin Lab Med; 2017 Dec; 37(4):787-802. PubMed ID: 29128069
[TBL] [Abstract][Full Text] [Related]
7. Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis.
Chen X; Cherian S
Clin Lab Med; 2017 Dec; 37(4):753-769. PubMed ID: 29128067
[TBL] [Abstract][Full Text] [Related]
8. Tumor heterogeneity makes AML a "moving target" for detection of residual disease.
Zeijlemaker W; Gratama JW; Schuurhuis GJ
Cytometry B Clin Cytom; 2014 Jan; 86(1):3-14. PubMed ID: 24151248
[TBL] [Abstract][Full Text] [Related]
9. Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
Mauvieux L; Miguet L; Fornecker L
N Engl J Med; 2018 Jun; 378(25):2442-3. PubMed ID: 29926700
[No Abstract] [Full Text] [Related]
10. Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
Ulrich BC
N Engl J Med; 2018 Jun; 378(25):2442. PubMed ID: 29926698
[No Abstract] [Full Text] [Related]
11. Acute Myeloid Leukemia Minimal Residual Disease Detection: The Difference from Normal Approach.
Wood BL
Curr Protoc Cytom; 2020 Jun; 93(1):e73. PubMed ID: 32311834
[TBL] [Abstract][Full Text] [Related]
12. Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
Löwenberg B; Valk PJM
N Engl J Med; 2018 Jun; 378(25):2443. PubMed ID: 29924951
[No Abstract] [Full Text] [Related]
13. Monitoring of minimal residual disease in acute myeloid leukemia: methods and best applications.
Jorgensen JL; Chen SS
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S49-53. PubMed ID: 22035748
[TBL] [Abstract][Full Text] [Related]
14. Beware clonal haematopoiesis following chronic lymphocytic leukaemia treatment.
Claxton DF
Br J Haematol; 2022 Jul; 198(1):9-10. PubMed ID: 35362550
[No Abstract] [Full Text] [Related]
15. Clonal Hematopoiesis after Induction Chemotherapy for Acute Myeloid Leukemia.
Steensma DP; Ebert BL
N Engl J Med; 2018 Mar; 378(13):1244-1245. PubMed ID: 29590545
[No Abstract] [Full Text] [Related]
16. [Advances in minimal residual disease detection with flow cytometry in childhood acute myeloid leukemia].
Feng JH; Xu XJ; Tang YM
Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):231-4. PubMed ID: 23751588
[No Abstract] [Full Text] [Related]
17. A refined approach to detect and measure minimal residual disease in childhood acute myeloid leukemia by flow cytometry.
Capolunghi F; Capponi C; De Stefani B; Luciani M; Locatelli F; Muraca M; Carsetti R
Am J Hematol; 2014 Mar; 89(3):343-4. PubMed ID: 24265183
[No Abstract] [Full Text] [Related]
18. Combining flow cytometry and
Guolo F; Minetto P; Clavio M; Miglino M; Galaverna F; Raiola AM; Di Grazia C; Colombo N; Pozzi S; Ibatici A; Bagnasco S; Guardo D; Kunkl A; Ballerini F; Ghiggi C; Lemoli RM; Gobbi M; Bacigalupo A
Haematologica; 2017 Sep; 102(9):e348-e351. PubMed ID: 28495917
[No Abstract] [Full Text] [Related]
19. [Detection of minimal residual disease in leukemia using flow cytometry].
Muroi K
Rinsho Ketsueki; 2008 Jun; 49(6):397-407. PubMed ID: 18646607
[No Abstract] [Full Text] [Related]
20. Minimal/Measurable Residual Disease Detection in Acute Leukemias by Multiparameter Flow Cytometry.
Fuda F; Chen W
Curr Hematol Malig Rep; 2018 Dec; 13(6):455-466. PubMed ID: 30446941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]